|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
|
|---|---|---|
| Revenue | ||
| Expenses | ||
| Research and development | ||
| General and administrative | ||
| Depreciation and amortization | ||
| Finance costs | ||
| Foreign exchange | ||
| Expenses | ||
| Loss before other items | ||
| Other items | ||
| Change in fair value of derivative financial liability | ||
| Other income | ||
| Loss on sale of vehicle | ||
| Gain on write-off of trade payables | ||
| Loss and comprehensive loss | ||
| Basic loss per share | ||
| Diluted loss per share | ||
| Weighted average number of common shares outstanding |
Loading...
